|
Real-time Estimate
Cboe BZX
15:59:49 2026-08-25 EDT
|
5-day change | 1st Jan Change | ||
| 13.58 USD | +5.64% |
|
+11.95% | +138.76% |
| 08-14 | BofA Adjusts Price Target on Candel Therapeutics to $12 From $9 | MT |
| 08-13 | Candel Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Chart: Technical Analysis
Stock exchange
Nasdaq
CADL 13.58 $
+5.64%
16.19M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| CADL | 13.58USD | +5.64% | 16.19M $ | |
CBOE
| CADL | 13.58USD | +5.80% | 389K $ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 13.5 | 13.5 | 13.13 |
| Spread/Res. | -0.07% | -0.07% | +2.74% |
| Spread/Supp. | +20.12% | +69.26% | +78.91% |
| Support | 11.23 | 7.97 | 7.54 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- CADL Stock
- Charts Candel Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
